Suspended

CCMAPThe Clalit Comprehensive-Care for Multimorbid Adults Project

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Nurse-physician comprehensive care

Other
Who is being recruted

Pathologic Processes+1

+ Pathological Conditions, Signs and Symptoms

+ Disease Attributes

From 18 to 95 Years
+16 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Services Research Study

Interventional
Study Start: March 2013
See protocol details

Summary

Principal SponsorMeir Medical Center
Last updated: April 29, 2015
Sourced from a government-validated database.Claim as a partner

Study start date: March 1, 2013

Actual date on which the first participant was enrolled.

Patients with multi-morbidities pose a significant challenge for healthcare organizations because they require continuity of care among a wide range of long-term therapeutic paradigms for many different types of diseases. The current study is based on a treatment model entailing a nurse-primary care physician team to provide care for patients with multiple morbidities. Patients in the intervention group who agreed and signed the consent form to participate in the study will receive treatment by the physician - nurse team in accordance with the components of the Clalit's Comprehensive Care for Mutlimorbid Adults Project model. Components of the intervention include: Comprehensive assessment of the patient's and family's needs Coordinated care plan based on integrated care guides "Multimorbid Action Plan" for patients All-inclussive patient centered care and caregiver support Proactive monitoring according to the plan. Patients in the control groups will receive usual care in their primary care clinics. The Usual Care Survey control group will complete study questionnaires at 6, 12 and 24 months after enrollement. The Usual Care Blinded group will be assessed only retrospectively based on deidentified information from Clalit's admistrative databases.

Principal SponsorMeir Medical Center
Last updated: April 29, 2015
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

1800 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Services Research Study

These studies look at how healthcare is delivered, managed, and organized. They aim to improve care quality, patient experience, and access to treatment.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 95 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Pathologic ProcessesPathological Conditions, Signs and SymptomsDisease AttributesChronic Disease

Criteria

3 inclusion criteria required to participate
2 or more chronic conditions

ACG system high risk probabilty score - 4% Highest Risk Score

Age 18 and older

13 exclusion criteria prevent from participating
Active (receipt of oncology chemotherapy , radiotherapy or other oncology treatment during the past 3 years)

Bedridden patients

Clalit Healthcare Services employees

Cognitive failure

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

3 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Comprehensive self management support and care coordination by a nurse-primary care physician team

Group II

No Intervention
Patients will receive usual primary care and asked to complete questionnaires on four time points throughout the study

Group III

No Intervention
Patients will receive usual primary care.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 13 locations

Ashdod A

Ashdod, IsraelOpen Ashdod A in Google Maps

Ashdod D

Ashdod, Israel

Azur

Azor, Israel

Arlozorov

Bat Yam, Israel
Suspended13 Study Centers